S100A2 induces metastasis in non-small cell lung cancer

Clinical Cancer Research

Volumn 15, Issue 1, 2009, Pages 22-29

  Bulk, Etmar ^a   Sargin, Bulent ^a   Krug, Utz ^a   Hascher, Antje ^a   Jun, Yu ^a   Knop, Markus ^a   Kerkhoff, Claus ^a   Gerke, Volker ^a   Liersch, Ruediger ^a   Mesters, Rolf M ^a   Hotfilder, Marc ^a   Marra, Alessandro ^b   Koschmieder, Steffen ^a   Dugas, Martin ^a   Berdel, Wolfgang E ^a   Serve, Hubert ^a   Muller Tidow, Carsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Clinic of Urology and Pediatric Urology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN S 100; PROTEIN S 100A2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CANCER MODEL; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; EARLY CANCER; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTACTIC FACTORS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; PROGNOSIS; RNA, MESSENGER; S100 PROTEINS; TRANSFECTION;

EID: 58849106387     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0953     Document Type: Article

References (47)

1. Herbst RS, Bunn PA, Jr. Targeting the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res 2003,9:5813-24.
2. Jemal A, MurrayT, Ward E, et al. Cancer Statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
4. Melchiori A, Albini A, Ray MJ, Stetler-Stevenson WG. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res 1992;52:2353-6.
5. Kielbassa-Schnepp K. StreyA, Janning A, Missiaen L, Nilius B, Gerke V. Endothelial intracellular Ca2+ release following monocyte adhesion is required for the transendothelial migration of monocytes. Cell Calcium 2001;30:29-40.
6. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J Invest Dermatol 1996, 106:989-92.
7. Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003;60:569-80.
8. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-51.
9. Arai K.TerataniT, Nozawa R.YamadaT. Immunohisto chemical investigation of S100A9 expression in pulmonary adenocarcinoma. S100A9 expression is associated with tumor differentiation. Oncol Rep 2001,8:591-6.
10. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24.
11. Battling B, Rehbein G. SchmittWD, Hofmann HS, Silber RE, Simm A. S100A2-100Pexpression profile and diagnosis of non-small cell lung carcinoma, impairment by advanced tumor stages and neoadjuvant chemotherapy. Eur J Cancer 2007;43:1935-43.
12. Diederichs S, Bulk E, Steffen B, et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 2004;64:5564-9.
13. Garrett SG, Varney KM, Weber DJ, Bresnic AR. S100A4, a Mediator of Metastasis. J Biol Chem 2006;281:677-80.
14. 2+- binding protein family. Genes Dev1989;3:1086-93.
15. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein S100A4: role in tumor progression and metastasis. Br J Cancer 2005:92: 1955-8.
16. Maelandsmo GM, FlorenesVA, MellingsaeterTHovig E, Kerbel RS, Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 1997;74:464 - 9.
17. Wang G, Platt-Higgins A, Carroll J, et al. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 2006:66:1199-207
18. TianT. Hao J, Xu A, et al. Determination of metastasis associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 2007,98 1265 - 74.
19. Heizmann CW, Fritz G. Schafer BW S100 proteins: structure, functions and pathology. Front Biosci 2002, 7:d1356-668.
20. Feng G, Xu X.Youssef EM, Lotan R, Diminished Expression of S100A2, a Putative Tumor Suppressor, at Early Stage of Human Lung Carcinogenesis. Cancer Res 2001:61:7999-8004.
21. Liu D, Rudland PS, Sibson, DR, Platt-Higgins A, Barraclough R. Expression of calcium-binding protein S100A2 in breast lesions. Br J Cancer 2000:83 1473-9.
22. NCBI Gene Expression Omnibus (GEO) DataSets Genomic approach to refine prognosis for adjuvant therapy in early stage non-small cell lung carcinoma (GSE3593 record).
23. Potti A. Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small- cell lung cancer. N EnglJ Med 2006:355:570 - 80
24. Schwäble J, Choudhary CThiede C, et al. RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation Blood 2005,105:2107 -14
25. Müller-Tidow C, Diederichs S, Bulk E, et al. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 2005:65 1778-82.
26. Dowen SE, Crnogorac-JurcevicT Gangeswaran R, et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 2005:166:81-92
27. Bulk E, HascherA, Liersch R, et al Adjuvant therapy with small hairpin RNAi prevents NSCLC development in mice. Cancer Res 2008;68:1896-904.
28. ChangY, Wu C, LeeY. Surgical treatment of sychronous multiple primary lung cancers: Experience of 92 patients. J Thorac Cardiovasc Surg 2007;134:630-7.
29. Raponi M, Zhang YYu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 2006;66: 7466-72.
30. Lu Y Lemon W, Liu PY, et al. A gene expression signature predicts survival of patients with stage I non- small cell lung cancer. PLoS Med 2006;3:e467.
31. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-57.
32. Crnogorac-JurcevicT, Missiaglia E, Blaveri E, et al. Molecularalterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003;201:63- 74.
33. RibeA, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol 2003;16:505-11.
34. Komatsu K, Murata K, Kameyama M, et al. Expres sion of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology 2002;63:192-200.
35. El-Rifai W, Moskaluk CA, Abdrabbo MK, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002;62:6823-6.
36. Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger AM. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res 2003;23:2043-51.
37. Hsieh HL, Schafer BW, Sasaki N, Heizmann CW. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 2003;307:375-81.
38. Harpio R, Einarsson R. S100 proteins as ancer biomarkers with focus on S100B in malignant melanoma. Clin Biochem 2004;37:512-8.
39. Saleem M, Kweon M, Johnson JJ, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. PNAS 2006;103:14825-30.
40. Arumugam T, Simeone DM, Van Golen K, Logs don CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005;11:5356-64.
41. Smith SL, Gugger M, Hoban P, et al. S100A2 is strongly expressed in airway basal cells, prenoplastic bronchial lesions and primary non-small cell lung carcinomas. BrJ Cancer 2004;91:1515-24.
42. Ohuchida K, Mizumoto K, MiyasakaY et al. Over expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. J Pathol 2007; 213:275-82.
43. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998;49:407-24.
44. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-8.
45. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991:324:1 -8.
46. Mori S, UedaT, Kuratsu S, Hosono N, Izawa K, Uchida A. Suppression of pulmonary metastasis by angiogenesis inhibitorTNP-470 in murine osteosarcoma. Int J Cancer 1995;61:148-52.
47. Felsenstein J. PHYLIP (Phytogeny Inference Package) version 3.5c. Distributed by the author. Department of Genetics, University of Washington, Seattle 1993.